|
1
|
Jiang Z, Cui X, Qu P, Shang C, Xiang M, Wang J. Roles and mechanisms of puerarin on cardiovascular disease：A review. Biomed Pharmacother 2022; 147:112655. [DOI: 10.1016/j.biopha.2022.112655] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2021] [Revised: 01/13/2022] [Accepted: 01/16/2022] [Indexed: 12/13/2022] Open
|
|
2
|
Fang X, Dong S, Wu Y, He Y, Lu M, Shi D, Feng N, Yin S, Jiang Y, Zhang A, Ding Y, Zhang Q, Tang J, Zhang W, He X. Ameliorated biomechanical properties of carotid arteries by puerarin in spontaneously hypertensive rats. BMC Complement Med Ther 2021; 21:173. [PMID: 34154575 PMCID: PMC8216761 DOI: 10.1186/s12906-021-03345-8] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2021] [Accepted: 06/02/2021] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND An emerging body of evidence indicates that puerarin (PUE) plays an important role in the treatment of angina pectoris, myocardial ischemia-reperfusion injury, hypertension and other cardiovascular diseases, but how PUE affects the vascular remodeling of hypertensive rats has not been reported yet. This study aimed to investigate the effect and mechanism of PUE on carotid arteries of spontaneously hypertensive rats (SHR) to provide the basis for the clinical application of PUE. METHODS Thirty male SHR and six male Wistar Kyoto rats (WKY) aged 3 months were used in this study, SHR rats were randomly divided into 5 groups, PUE(40 or 80 mg/kg/d, ip) and telmisartan (TELMI) (30 mg/kg/d, ig) were administrated for 3 months. We use DMT myography pressure-diameter system to investigate biomechanical properties of carotid arteries, 10 μM pan-classical transient receptor potential channels (TRPCs) inhibitor SKF96365, 200 nM specific TRPC6 inhibitor SAR7334 and 100 μM Orai1 inhibitor ANCOA4 were used in the mechanical test. RESULTS PUE can significantly decrease systolic and diastolic blood pressure, long-term administration of PUE resulted in a mild reduction of thickness and inner diameter of carotid artery. PUE ameliorate NE-response and vascular remodeling mainly through inhibiting TRPCs channel activities of VSMC. CONCLUSION PUE can ameliorate biomechanical remodeling of carotid arteries through inhibiting TRPCs channel activities of VSMC in spontaneously hypertensive rats.
Collapse
Affiliation(s)
- Xiaoxia Fang
- Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000 China
| | - Sheng Dong
- Department of Anatomy, Hubei University of Medicine, Shiyan, 442000 China
| | - Yun Wu
- Department of Anatomy, Hubei University of Medicine, Shiyan, 442000 China
| | - Yun He
- Department of Ultrasound, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000 China
| | - Min Lu
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, 442000 China
| | - Dandan Shi
- Department of Anatomy, Hubei University of Medicine, Shiyan, 442000 China
| | - Na Feng
- Department of Anatomy, Hubei University of Medicine, Shiyan, 442000 China
| | - Songhe Yin
- Department of Neurology, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000 China
| | - Yan Jiang
- Department of Ultrasound, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000 China
| | - Anhua Zhang
- Department of Anatomy, Hubei University of Medicine, Shiyan, 442000 China
| | - Yan Ding
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, 442000 China
| | - Qiufang Zhang
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, 442000 China
| | - Junming Tang
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, 442000 China
| | - Wenjun Zhang
- Department of Ultrasound, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000 China
| | - Xiju He
- Department of Anatomy, Hubei University of Medicine, Shiyan, 442000 China
- Department of Ultrasound, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000 China
- Hubei Key Laboratory of Embryonic Stem Cell Research, Hubei University of Medicine, Shiyan, 442000 China
| |
Collapse
|
|
3
|
Luna-Vázquez FJ, Ibarra-Alvarado C, Rojas-Molina A, Rojas-Molina I, Zavala-Sánchez MA. Vasodilator compounds derived from plants and their mechanisms of action. Molecules 2013; 18:5814-57. [PMID: 23685938 DOI: 10.3390/molecules18055814] [Citation(s) in RCA: 49] [Impact Index Per Article: 4.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/19/2013] [Revised: 04/24/2013] [Accepted: 05/07/2013] [Indexed: 12/31/2022] Open
Abstract
The present paper reviews vasodilator compounds isolated from plants that were reported in the past 22 years (1990 to 2012) and the different mechanisms of action involved in their vasodilator effects. The search for reports was conducted in a comprehensive manner, intending to encompass those metabolites with a vasodilator effect whose mechanism of action involved both vascular endothelium and arterial smooth muscle. The results obtained from our bibliographic search showed that over half of the isolated compounds have a mechanism of action involving the endothelium. Most of these bioactive metabolites cause vasodilation either by activating the nitric oxide/cGMP pathway or by blocking voltage-dependent calcium channels. Moreover, it was found that many compounds induced vasodilation by more than one mechanism. This review confirms that secondary metabolites, which include a significant group of compounds with extensive chemical diversity, are a valuable source of new pharmaceuticals useful for the treatment and prevention of cardiovascular diseases.
Collapse
|